Reservoir assembly for providing cardioplegic solution containing bicarbonate ion, and method for manufacturing the same

Patent metadata

Field	Value
Publication number	US-12472299-B2
Application number	US-202017600274-A
Country	US
Kind code	B2
Filing date	Apr 3, 2020
Priority date	Apr 4, 2019
Publication date	Nov 18, 2025
Grant date	Nov 18, 2025

Abstract

The object of the invention is to provide a novel reservoir assembly for providing a cardioplegic solution and a method for manufacturing the same. An aspect of the invention is to provide a reservoir assembly for providing a cardioplegic solution, comprising a multi-chamber reservoir; a gas-impermeable outer package packaging the multi-chamber reservoir; an oxygen detection agent and a deoxygenation agent in a space part between the multi-chamber reservoir and the outer package, wherein the deoxygenation agent neither generates nor absorbs carbon dioxide, wherein the multi-chamber reservoir comprises at least a first chamber, a second chamber, and a first separator wall that separates the two chambers, the first chamber holds a first medical liquid, the second chamber holds a second medical liquid containing bicarbonate ions, one or both of the first medical liquid and the second medical liquid contains potassium ions, the cardioplegic solution comprises the first medical liquid and the second medical liquid, and the cardioplegic solution contains bicarbonate ions of 5 to 20 mEq/L and potassium ions of 5 to 35 mEq/L. Another aspect of the invention is to provide a method for manufacturing the reservoir assembly for providing a cardioplegic solution.

First claim

The invention claimed is:

1 . A method for manufacturing a reservoir assembly for providing a cardioplegic solution, comprising:
sterilizing a multi-chamber reservoir comprising at least a first chamber that holds a first medical liquid containing magnesium ions and calcium ions, a second chamber that holds a second medical liquid containing bicarbonate ions, and a first separator wall that separates the two chambers; packaging the multi-chamber reservoir, an oxygen detection agent, and a deoxygenation agent in a gas-impermeable outer package, wherein the deoxygenation agent neither generates nor absorbs carbon dioxide; filling carbon dioxide into the outer package; and sealing the outer package after filling carbon dioxide; wherein one or both of the first medical liquid and the second medical liquid contains potassium ions, the cardioplegic solution is provided by mixing the first medical liquid and the second medical liquid, the cardioplegic solution contains bicarbonate ions of 8 to 12 mEq/L, calcium ions of 0.5 to 5 mEq/L, magnesium ions of 2 to 55 mEq/L, potassium ions of 5 to 35 mEq/L, and sodium ions of 100 to 150 mEq/L, the cardioplegic solution has a pH of 7.6 to 8, and the volume ratio of the first medical liquid to the second medical liquid is 1:1 to 4:1.

2 . The method according to claim 1 , wherein the deoxygenation agent includes a cross-linked polymer having carbon-carbon unsaturated bonds.

3 . The method according to claim 1 , wherein carbon dioxide is filled into the outer package in an amount such that, after the bicarbonate ion concentration in the second medical liquid has reached an equilibrium with the carbon dioxide concentration in a space part between the multi-chamber reservoir and the outer package, the bicarbonate ion concentration of the second medical liquid is within 98% to 102% of the bicarbonate ion concentration in the second medical liquid before being sterilized.

4 . A method for manufacturing a reservoir assembly for providing a cardioplegic solution, comprising:
sterilizing a multi-chamber reservoir comprising at least a first chamber that holds a first medical liquid containing magnesium ions and calcium ions, a second chamber that holds a second medical liquid containing bicarbonate ions, and a first separator wall that separates the two chambers; packaging the multi-chamber reservoir, an oxygen detection agent, and a deoxygenation agent in a gas-impermeable outer package, wherein the deoxygenation agent neither generates nor absorbs carbon dioxide; filling carbon dioxide into the outer package; and sealing the outer package after filling carbon dioxide; wherein the cardioplegic solution is provided by mixing the first medical liquid and the second medical liquid, the cardioplegic solution contains bicarbonate ions of 8 to 12 mEq/L, calcium ions of 0.5 to 5 mEq/L, magnesium ions of 2 to 55 mEq/L, and potassium ions of 5 to 35 mEq/L, the first medical liquid contains sodium ions of 108.9±10 mEq/L, potassium ions of 21.1±2 mEq/L, calcium ions of 3.4±0.3 mEq/L, and magnesium ions of 45.7±5 mEq/L, the first medical liquid having an osmotic pressure of 275 to 300 mOsm/kg, and the second medical liquid contains sodium ions of 146±10 mEq/L, potassium ions of 4±0.4 mEq/L, and bicarbonate ions of 33.3±3 mEq/L, the second medical liquid having an osmotic pressure of 275 to 300 mOsm/kg.

5 . A method for manufacturing a reservoir assembly for providing a cardioplegic solution, comprising:
sterilizing a multi-chamber reservoir comprising at least a first chamber that holds a first medical liquid containing magnesium ions and calcium ions, a second chamber that holds a second medical liquid containing bicarbonate ions, and a first separator wall that separates the two chambers; packaging the multi-chamber reservoir, an oxygen detection agent, and a deoxygenation agent in a gas-impermeable outer package, wherein the deoxygenation agent neither generates nor absorbs carbon dioxide; filling carbon dioxide into the outer package; and sealing the outer package after filling carbon dioxide; wherein the multi-chamber reservoir comprises at least a first chamber, a second chamber, a third chamber, a first separator wall that separates the first chamber and the second chamber, and a second separator wall that separates the second chamber and the third chamber, the first chamber holds a first medical liquid including sodium ions of 108.9±10 mEq/L, potassium ions of 21.1±2 mEq/L, calcium ions of 3.4±0.3 mEq/L, and magnesium ions of 45.7±5 mEq/L, the first medical liquid having an osmotic pressure of 275 to 300 mOsm/kg, the second chamber holds a second medical liquid including sodium ions of 146±10 mEq/L, potassium ions of 4±0.4 mEq/L, and bicarbonate ions of 33.3±3 mEq/L, the second medical liquid having an osmotic pressure of 275 to 300 mOsm/kg, the volume ratio of the first medical liquid to the second medical liquid is 7:3, the cardioplegic solution is provided by mixing the first medical liquid and the second medical liquid, the cardioplegic solution including sodium ions of 110 to 130 mEq/L, potassium ions of 14 to 17 mEq/L, calcium ions of 2 to 3 mEq/L, magnesium ions of 30 to 35 mEq/L, and bicarbonate ions of 8 to 12 mEq/L, the cardioplegic solution has a pH of 7.6 to 8 and osmotic pressure of 275 to 300 mOsm/kg, and the deoxygenation agent includes a cross-linked polymer having carbon-carbon unsaturated bonds.

6 . The method according to claim 4 , wherein the deoxygenation agent includes a cross-linked polymer having carbon-carbon unsaturated bonds.

7 . The method according to claim 4 , wherein the cardioplegic solution has a pH of 7.6 to 8.

8 . The method according to claim 4 , wherein the volume ratio of the first medical liquid to the second medical liquid is 1:1 to 4:1.

9 . The method according to claim 4 , wherein carbon dioxide is filled into the outer package in an amount such that, after the bicarbonate ion concentration in the second medical liquid has reached an equilibrium with the carbon dioxide concentration in a space part between the multi-chamber reservoir and the outer package, the bicarbonate ion concentration of the second medical liquid is within 98% to 102% of the bicarbonate ion concentration in the second medical liquid before being sterilized.

10 . The method according to claim 5 , wherein carbon dioxide is filled into the outer package in an amount such that, after the bicarbonate ion concentration in the second medical liquid has reached an equilibrium with the carbon dioxide concentration in a space part between the multi-chamber reservoir and the outer package, the bicarbonate ion concentration of the second medical liquid is within 98% to 102% of the bicarbonate ion concentration in the second medical liquid before being sterilized.

Assignees

• Fuso Pharmaceutical Ind

Inventors

• Tokuoka Shogo
• Tanaka Yasushige
• Inoue Shin-Ichi
• Mori Tomoko

Classifications

• B65D81/32

  for packaging two or more different materials which must be maintained separate prior to use in admixture · CPC title

• A61M2207/00

  Methods of manufacture, assembly or production · CPC title

• A61M2205/3327

  Measuring · CPC title

• A61K33/14

  Alkali metal chlorides; Alkaline earth metal chlorides · CPC title

• A61K33/00

  Medicinal preparations containing inorganic active ingredients · CPC title